Concepts (99)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Ventilator Weaning | 2 | 2021 | 144 | 1.370 |
Why?
|
Respiratory Insufficiency | 2 | 2021 | 1142 | 0.590 |
Why?
|
Embolism, Air | 1 | 2014 | 113 | 0.530 |
Why?
|
Klebsiella Infections | 1 | 2014 | 148 | 0.510 |
Why?
|
Intracranial Embolism | 1 | 2014 | 215 | 0.470 |
Why?
|
Klebsiella pneumoniae | 1 | 2014 | 281 | 0.470 |
Why?
|
Interleukin-6 | 2 | 2021 | 3192 | 0.410 |
Why?
|
Coronavirus Infections | 4 | 2021 | 3163 | 0.220 |
Why?
|
Respiration, Artificial | 3 | 2021 | 2428 | 0.210 |
Why?
|
Influenza, Human | 2 | 2021 | 1342 | 0.200 |
Why?
|
Pulmonary Gas Exchange | 1 | 2020 | 377 | 0.180 |
Why?
|
Respiratory Mucosa | 1 | 2021 | 465 | 0.160 |
Why?
|
Pneumonia, Viral | 3 | 2020 | 3276 | 0.160 |
Why?
|
Virus Internalization | 1 | 2021 | 466 | 0.160 |
Why?
|
Respiratory Mechanics | 1 | 2020 | 643 | 0.150 |
Why?
|
Influenza A Virus, H1N1 Subtype | 1 | 2020 | 463 | 0.150 |
Why?
|
Fluid Therapy | 2 | 2020 | 608 | 0.150 |
Why?
|
Microbial Sensitivity Tests | 1 | 2021 | 1903 | 0.140 |
Why?
|
Microfluidic Analytical Techniques | 1 | 2021 | 759 | 0.140 |
Why?
|
Cystitis | 1 | 2014 | 87 | 0.140 |
Why?
|
Oxygen Inhalation Therapy | 1 | 2016 | 362 | 0.120 |
Why?
|
Emphysema | 1 | 2014 | 211 | 0.120 |
Why?
|
Pandemics | 3 | 2020 | 6922 | 0.110 |
Why?
|
Sequence Analysis, RNA | 1 | 2021 | 2047 | 0.110 |
Why?
|
Host-Pathogen Interactions | 1 | 2021 | 1489 | 0.110 |
Why?
|
Single-Cell Analysis | 1 | 2021 | 2167 | 0.100 |
Why?
|
Internal Medicine | 1 | 2016 | 999 | 0.090 |
Why?
|
Antiviral Agents | 1 | 2021 | 2744 | 0.090 |
Why?
|
Teaching | 1 | 2016 | 1193 | 0.090 |
Why?
|
Fellowships and Scholarships | 1 | 2016 | 964 | 0.090 |
Why?
|
Patient Selection | 1 | 2021 | 4322 | 0.090 |
Why?
|
Odds Ratio | 1 | 2021 | 10019 | 0.080 |
Why?
|
Critical Illness | 2 | 2021 | 2471 | 0.080 |
Why?
|
Intensive Care Units | 2 | 2021 | 3422 | 0.080 |
Why?
|
Hospital Mortality | 1 | 2021 | 5117 | 0.080 |
Why?
|
Administration, Inhalation | 2 | 2020 | 1106 | 0.070 |
Why?
|
Lung | 2 | 2021 | 9617 | 0.070 |
Why?
|
Critical Care | 1 | 2016 | 2490 | 0.060 |
Why?
|
Body Mass Index | 1 | 2021 | 12426 | 0.060 |
Why?
|
Middle Aged | 6 | 2021 | 215428 | 0.060 |
Why?
|
Communication | 1 | 2016 | 3395 | 0.060 |
Why?
|
Cathepsin L | 1 | 2021 | 82 | 0.050 |
Why?
|
Sepsis | 1 | 2014 | 2438 | 0.050 |
Why?
|
Predictive Value of Tests | 1 | 2016 | 15316 | 0.050 |
Why?
|
Prone Position | 1 | 2020 | 179 | 0.050 |
Why?
|
Male | 6 | 2021 | 351848 | 0.050 |
Why?
|
Coronavirus | 1 | 2021 | 147 | 0.050 |
Why?
|
Time Factors | 1 | 2021 | 41295 | 0.040 |
Why?
|
Obesity | 1 | 2021 | 12008 | 0.040 |
Why?
|
Humans | 12 | 2021 | 709431 | 0.040 |
Why?
|
Adult | 4 | 2021 | 212298 | 0.040 |
Why?
|
Renal Replacement Therapy | 1 | 2020 | 255 | 0.040 |
Why?
|
Influenza A virus | 1 | 2021 | 453 | 0.040 |
Why?
|
Respiratory System | 1 | 2021 | 560 | 0.040 |
Why?
|
Reference Standards | 1 | 2020 | 890 | 0.040 |
Why?
|
Patient Positioning | 1 | 2020 | 331 | 0.040 |
Why?
|
Bronchi | 1 | 2021 | 847 | 0.040 |
Why?
|
Prostaglandins I | 1 | 2016 | 13 | 0.040 |
Why?
|
Vasoconstrictor Agents | 1 | 2020 | 632 | 0.040 |
Why?
|
Internship and Residency | 1 | 2016 | 5527 | 0.040 |
Why?
|
Aged | 4 | 2021 | 162592 | 0.040 |
Why?
|
Positive-Pressure Respiration | 1 | 2020 | 599 | 0.040 |
Why?
|
Helium | 1 | 2016 | 120 | 0.040 |
Why?
|
Demography | 1 | 2021 | 1617 | 0.040 |
Why?
|
Organ Specificity | 1 | 2021 | 2073 | 0.040 |
Why?
|
Vasodilator Agents | 1 | 2020 | 1013 | 0.040 |
Why?
|
High-Throughput Screening Assays | 1 | 2021 | 932 | 0.040 |
Why?
|
Serine Endopeptidases | 1 | 2021 | 1125 | 0.030 |
Why?
|
Lung Diseases, Obstructive | 1 | 2016 | 318 | 0.030 |
Why?
|
Female | 5 | 2021 | 377269 | 0.030 |
Why?
|
Renal Insufficiency | 1 | 2020 | 797 | 0.030 |
Why?
|
Respiratory Tract Infections | 1 | 2021 | 960 | 0.030 |
Why?
|
Cell Culture Techniques | 1 | 2021 | 1735 | 0.030 |
Why?
|
Pneumonia, Ventilator-Associated | 1 | 2016 | 256 | 0.030 |
Why?
|
Equipment Design | 1 | 2021 | 3636 | 0.030 |
Why?
|
Bronchodilator Agents | 1 | 2016 | 507 | 0.030 |
Why?
|
Intubation, Intratracheal | 1 | 2020 | 1318 | 0.030 |
Why?
|
Extracorporeal Membrane Oxygenation | 1 | 2020 | 1232 | 0.020 |
Why?
|
Lung Diseases | 1 | 2020 | 1890 | 0.020 |
Why?
|
Massachusetts | 1 | 2021 | 8754 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2016 | 2109 | 0.020 |
Why?
|
Adrenal Cortex Hormones | 1 | 2016 | 1850 | 0.020 |
Why?
|
Cell Line | 1 | 2021 | 16795 | 0.020 |
Why?
|
Comorbidity | 1 | 2020 | 10621 | 0.020 |
Why?
|
Hypertension, Pulmonary | 1 | 2016 | 1484 | 0.020 |
Why?
|
Aged, 80 and over | 2 | 2021 | 58752 | 0.020 |
Why?
|
Oxygen | 1 | 2016 | 4148 | 0.020 |
Why?
|
Gene Expression Profiling | 1 | 2021 | 9584 | 0.020 |
Why?
|
Referral and Consultation | 1 | 2016 | 3448 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2020 | 5231 | 0.010 |
Why?
|
Smoking | 1 | 2020 | 8940 | 0.010 |
Why?
|
Hospitalization | 1 | 2021 | 9632 | 0.010 |
Why?
|
Hypertension | 1 | 2020 | 8150 | 0.010 |
Why?
|
Cohort Studies | 1 | 2020 | 39650 | 0.010 |
Why?
|
Anti-Bacterial Agents | 1 | 2016 | 7071 | 0.010 |
Why?
|
Risk Factors | 1 | 2021 | 70264 | 0.010 |
Why?
|
Young Adult | 1 | 2020 | 56163 | 0.010 |
Why?
|
Retrospective Studies | 1 | 2021 | 71151 | 0.010 |
Why?
|
United States | 1 | 2016 | 67177 | 0.010 |
Why?
|
Concepts
(99)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(41)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_